β-Arrestin2 expressed in mast cells regulates ciprofloxacin-induced pseudoallergy and IgE-mediated anaphylaxis

J Allergy Clin Immunol. 2019 Aug;144(2):603-606. doi: 10.1016/j.jaci.2019.04.024. Epub 2019 May 9.

Abstract

The adapter protein β-arrestin2 inhibits Mrgprb2 and FcεRI-mediated mast cell degranulation to attenuate pseudo-allergy and anaphylaxis. Thus, targeting β-arrestin2 in mast cells could provide novel therapeutic options for modulating pseudo-allergy and anaphylaxis.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Anaphylaxis / chemically induced
  • Anaphylaxis / immunology*
  • Anaphylaxis / pathology
  • Animals
  • Ciprofloxacin / adverse effects*
  • Ciprofloxacin / pharmacology
  • Drug Hypersensitivity / immunology*
  • Drug Hypersensitivity / pathology
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / immunology
  • Immunoglobulin E / immunology*
  • Mast Cells / immunology*
  • Mast Cells / pathology
  • Mice
  • Mice, Knockout
  • beta-Arrestin 2 / immunology*

Substances

  • Arrb2 protein, mouse
  • beta-Arrestin 2
  • Immunoglobulin E
  • Ciprofloxacin